Improved surgical margins with neoadjuvant versus adjuvant chemotherapy in clinical stage I resectable pancreatic adenocarcinoma: A National Cancer Database study

Authors

Geoffrey Bellini, Advocate Aurora HealthFollow
Samit K. Datta, Advocate Aurora HealthFollow
Nicholas Sich, Advocate Aurora HealthFollow
Maharaj Singh, Advocate Aurora HealthFollow
James Weese, Advocate Aurora HealthFollow
Federico A. Sanchez, Advocate Aurora HealthFollow
Nalini M. Guda, Advocate Aurora HealthFollow
Wesley Papenfuss, Advocate Aurora HealthFollow
Aaron H. Chevinsky, Advocate Aurora HealthFollow

Recommended Citation

Bellini G, Datta SK, SIch N, Singh M, Weese JL, Sanchez FA, Guda N, Papenfuss WA, Chevinsky A. Improved surgical margins with neoadjuvant versus adjuvant chemotherapy in clinical stage I resectable pancreatic adenocarcinoma: A National Cancer Database study. Journal of Clinical Oncology. 2020;38(4S):651. doi: 10.1200/JCO.2020.38.4_suppl.651.

Affiliations

Aurora St. Luke's Medical Center

Aurora Cancer Care, Advocate Aurora Health

Document Type

Article